MENU
OGEN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Oragenics (OGEN) Ownership - Who owns Oragenics?
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.9M
P/E Ratio
N/A
Total Cash
3.42M
Projected Growth
N/A
Total Debt
2.55M
Revenue
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
4.78
Total Debt/Equity
0.57
Revenue/Share
null USD as % of share price
Fundamentals
OGEN
Capitalization
2.9M
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
3.42M
Total Cash/Share
4.78
Total Debt
2.55M
Total Debt/Equity
0.57
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
138K
P/B Ratio
21.05
Cash Flow
N/A
Earnings
-30.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
21.5K
Current Ratio
1.04
Current Revenue Per Employee
16391.13
Dividends Per Share - Security
N/A
EBITDA
-10.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.70
Revenue To Assets
-279.18
Shares Held By Institutions
82K
Shares Outstanding - Current
716K
Total Liabilities
3.73M
Total Volume MTD
N/A
Value
-1
Gain YTD
-63.444
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
1990 Main Street
Phone
+1 813 286-7900
Employees
5
Web
https://www.oragenics.com